| Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares — Comtex07:31 AM ET 11/20/2025 Toronto, Ontario and Chicago, Illinois, Nov 20, 2025 (Newsfile Corp via COMTEX News Network) -- Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 20, 2025) - Medexus... |
| Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares — Comtex08:31 AM ET 11/17/2025 Toronto, Ontario and Chicago, Illinois, Nov 17, 2025 (Newsfile Corp via COMTEX News Network) -- Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 17, 2025) - Medexus... |
| Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection — Comtex06:07 PM ET 11/12/2025 Toronto, Ontario and Chicago, Illinois, Nov 12, 2025 (Newsfile Corp via COMTEX News Network) -- Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 12, 2025) - Medexus... |
| Medexus Schedules Second Fiscal Quarter 2026 Conference Call — Comtex05:31 PM ET 11/04/2025 Toronto, Ontario and Chicago, Illinois, Nov 04, 2025 (Newsfile Corp via COMTEX News Network) -- Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 4, 2025) - Medexus Pharmaceuticals... |